Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • sparks
    Senior Member
    • Mar 2008
    • 126

    #16
    @warren
    I think you misunderstood and that we are agreeing. Maybe I wasn't clear but I was trying to say if a read was mapped in first pass to the wrong location or incorrectly aligned (i.e. with mismatches when it should have had an indel) then it will stay that way as it doesn't get to the unmapped file.
    Using Bowtie(ungapped) then Novoalign and you'll have this problem.
    Using Novoalign/Novoalign with a low threshold on the first pass is OK and will produce the same results as just one run at high threshold.
    BWA as first aligner should be fine as it has low false positive rate.

    Comment

    • sparks
      Senior Member
      • Mar 2008
      • 126

      #17
      I think Heng Li and krobison have it right. You need to take more than the unmapped reads, you need to take pairs that are not properly aligned and alignments with the number of mismatches or score above some limit. The limit will depend on the first aligner used.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      27 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      43 views
      0 reactions
      Last Post SEQadmin2  
      Working...